Researchers at the University of Delaware are uncovering the role of fat tissue at the gene level. Their findings reveal that visceral fat, which surrounds vital organs, undergoes drastic gene expression changes linked to inflammation and disease. This breakthrough could pave the way for targeted treatments to improve metabolic health and combat obesity.
Ibra Fancher, assistant professor of kinesiology and applied physiology at the University of Delaware, works with adipose tissue samples in his lab at the Ammon Pinizzotto Biopharmaceutical Innovation Center on Star Campus. His research aims to determine targeted treatments for obesity.
(Source: Ashley Barnas Larrimore/ University of Delaware)
As many as 40 % of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the University of Delaware aims to tackle the issue by investigating obesity at the gene level.
Principal investigator Ibra Fancher, assistant professor of kinesiology and applied physiology in UD’s College of Health Sciences, discovered significant differences in gene expression in adipose tissue, more commonly known as fat. Formerly considered fat storage, adipose tissue is now recognized as a vital endocrine organ. Dysfunction in the tissue is linked to significant cardiovascular and metabolic diseases.
In the study published in Physiological Genomics, Fancher and colleagues examined how diet impacts gene expression in adipose tissue using an animal model. One group consumed a diet akin to a typical high-fat, high-caloric Western diet, while the other ate a standard chow for over a year.
“We expected to see robust changes in fat, and indeed, the adipose depots in the high-fat group were much different, showing significant changes related to poor diet and obesity,” Fancher said.
The study, funded by a federal National Institutes of Health grant to UD’s Center of Biomedical Research Excellence (Cobre) in Cardiovascular Health, found more than 300 genes were differentially expressed in subcutaneous adipose tissue (SAT), a less dangerous form of fat. In comparison, nearly 700 genes were differentially expressed in visceral adipose tissue (VAT). Visceral fat, or fat around vital organs, raises a person’s risk for significant health issues.
“The comparison of VAT to SAT is stark. The expansion of visceral fat, along with its inflammatory role in obesity and metabolic diseases, is particularly severe,” Fancher said. “This study highlights the impact of obesity, which often results from a poor diet and sedentary lifestyle, on specific adipose tissues, which is very likely a major factor affecting health. That makes the affected tissue a good target for interventions to protect other systems.”
Among the thousands of genes analyzed, Fancher’s research identified four genes related to metabolism, calcium handling and inflammation that warrant further investigation.
“We’re already looking to see if these genes are worthwhile pursuits in improving adipose tissue function in obesity,” Fancher said. “They could potentially be targeted with existing drugs or spawn new treatments specifically designed to influence these genes.”
An Innovative Approach
Fancher worked with Bruce Kingham, director of UD’s Sequencing and Genotyping Center at the Delaware Biotechnology Institute, and Shawn Polson, director of the Bioinformatics Data Science Core at UD’s Center for Bioinformatics and Computational Biology and Delaware INBRE, as well as a research professor in the Department of Computer and Information Sciences in the College of Engineering.
“Our core facilities provide access to the advanced technologies and expertise for RNA sequencing and bioinformatics that enable UD investigators to do this type of research,” Polson said. “In this project, when we analyzed the data, it very clearly pointed us to obesity-related genes and pathways that varied between VAT and SAT.”
From left to right, Shawn Polson, director of the Bioinformatics Data Science Core at UD’s Center for Bioinformatics and Computational Biology and Delaware INBRE, and research professor in the College of Engineering’s Department of Computer and Information Sciences; Ibra Fancher, assistant professor of kinesiology and applied physiology; Mark Shaw, research associate in UD’s Sequencing and Genotyping Center at the Delaware Biotechnology Institute, collaborated on this research.
Malak Alradi, a third-year doctoral student studying molecular biology and genetics, played a key role in organizing the genes into pathways to better understand their biological significance.
“Before I started this research, I thought fat was the same in the body, but when I saw the RNA sequencing and studied the different genes and pathways, I realized that VAT is affected by obesity far more than SAT,” Alradi said. “Our approach shows how interconnected these processes are and why targeting specific pathways could make a difference in obesity treatment.”
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
Stringent statistical methods also confirmed key findings about adipose depots, including changes in metabolism and inflammation. “That makes us feel really good about the genes we identified,” Fancher said. “It underscores the novelty of our findings.”
Fancher now plans to study gene expression in human adipose tissue. In collaboration with Dr. Caitlin Halbert, director of bariatric surgery at ChristianaCare, Fancher aims to determine whether previous findings apply to human samples.
He also noted the potential for sex differences. “Obesity influences the sexes very differently, so I would not be surprised if we found sex differences,” Fancher said. “Recognizing these differences is crucial to tailoring more personalized and targeted interventions.”
Original Article: A long-term high-fat diet induces differential gene expression changes in spatially distinct adipose tissue of male mice; Physiological Genomics; DOI:10.1152/physiolgenomics.00080.2024